Form D · Biotechnology
SOLX INC
Waltham, MA · CIK 0001118997
Offering snapshot reported Sep 11, 2015 · SEC filing
- Reported sold
- $2.25M Offering amount: $11M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 27, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 11, 2015 | Initial | $2,250,000 | No comparison | 5 | SEC filing |
| Dec 19, 2013 | Initial | $2,124,000 | No comparison | 3 | SEC filing |
| Jan 19, 2012 | Initial | $3,250,000 | No comparison | 3 | SEC filing |
| Oct 27, 2010 | Initial | $3,700,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- Not reported
Solx Europe Limited $1,687,765.70 Solx, Inc. $562,324.30
Source: Form D, filed Sep 11, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Adams | Director, Executive |
| Neil Akhurst | Director |
| Eric Bednarski | Director |
| Frank Flautt | Director |
| Frank L. Flautt, Iii | Director |
| Bosun Hau | Director |
| Jim Largent | Director |
| Kevin Mc Mahon | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
230 Second Avenue, Suite 120
Waltham, MA, 02451
Waltham, MA, 02451